| 1. |
- Ademuyiwa, Adesoji O., et al.
(författare)
-
Determinants of morbidity and mortality following emergency abdominal surgery in children in low-income and middle-income countries
- 2016
-
Ingår i: BMJ Global Health. - : BMJ Publishing Group Ltd. - 2059-7908. ; 1:4
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Child health is a key priority on the global health agenda, yet the provision of essential and emergency surgery in children is patchy in resource-poor regions. This study was aimed to determine the mortality risk for emergency abdominal paediatric surgery in low-income countries globally.Methods: Multicentre, international, prospective, cohort study. Self-selected surgical units performing emergency abdominal surgery submitted prespecified data for consecutive children aged <16 years during a 2-week period between July and December 2014. The United Nation's Human Development Index (HDI) was used to stratify countries. The main outcome measure was 30-day postoperative mortality, analysed by multilevel logistic regression.Results: This study included 1409 patients from 253 centres in 43 countries; 282 children were under 2 years of age. Among them, 265 (18.8%) were from low-HDI, 450 (31.9%) from middle-HDI and 694 (49.3%) from high-HDI countries. The most common operations performed were appendectomy, small bowel resection, pyloromyotomy and correction of intussusception. After adjustment for patient and hospital risk factors, child mortality at 30 days was significantly higher in low-HDI (adjusted OR 7.14 (95% CI 2.52 to 20.23), p<0.001) and middle-HDI (4.42 (1.44 to 13.56), p=0.009) countries compared with high-HDI countries, translating to 40 excess deaths per 1000 procedures performed.Conclusions: Adjusted mortality in children following emergency abdominal surgery may be as high as 7 times greater in low-HDI and middle-HDI countries compared with high-HDI countries. Effective provision of emergency essential surgery should be a key priority for global child health agendas.
|
|
| 2. |
- Thomas, HS, et al.
(författare)
-
- 2019
-
swepub:Mat__t
|
|
| 3. |
- Micah, Angela E., et al.
(författare)
-
Tracking development assistance for health and for COVID-19 : a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050
- 2021
-
Ingår i: The Lancet. - : Elsevier. - 0140-6736 .- 1474-547X. ; 398:10308, s. 1317-1343
-
Forskningsöversikt (refereegranskat)abstract
- Background The rapid spread of COVID-19 renewed the focus on how health systems across the globe are financed, especially during public health emergencies. Development assistance is an important source of health financing in many low-income countries, yet little is known about how much of this funding was disbursed for COVID-19. We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020. Methods We estimated domestic health spending and development assistance for health to generate total health-sector spending estimates for 204 countries and territories. We leveraged data from the WHO Global Health Expenditure Database to produce estimates of domestic health spending. To generate estimates for development assistance for health, we relied on project-level disbursement data from the major international development agencies' online databases and annual financial statements and reports for information on income sources. To adjust our estimates for 2020 to include disbursements related to COVID-19, we extracted project data on commitments and disbursements from a broader set of databases (because not all of the data sources used to estimate the historical series extend to 2020), including the UN Office of Humanitarian Assistance Financial Tracking Service and the International Aid Transparency Initiative. We reported all the historic and future spending estimates in inflation-adjusted 2020 US$, 2020 US$ per capita, purchasing-power parity-adjusted US$ per capita, and as a proportion of gross domestic product. We used various models to generate future health spending to 2050. Findings In 2019, health spending globally reached $8. 8 trillion (95% uncertainty interval [UI] 8.7-8.8) or $1132 (1119-1143) per person. Spending on health varied within and across income groups and geographical regions. Of this total, $40.4 billion (0.5%, 95% UI 0.5-0.5) was development assistance for health provided to low-income and middle-income countries, which made up 24.6% (UI 24.0-25.1) of total spending in low-income countries. We estimate that $54.8 billion in development assistance for health was disbursed in 2020. Of this, $13.7 billion was targeted toward the COVID-19 health response. $12.3 billion was newly committed and $1.4 billion was repurposed from existing health projects. $3.1 billion (22.4%) of the funds focused on country-level coordination and $2.4 billion (17.9%) was for supply chain and logistics. Only $714.4 million (7.7%) of COVID-19 development assistance for health went to Latin America, despite this region reporting 34.3% of total recorded COVID-19 deaths in low-income or middle-income countries in 2020. Spending on health is expected to rise to $1519 (1448-1591) per person in 2050, although spending across countries is expected to remain varied. Interpretation Global health spending is expected to continue to grow, but remain unequally distributed between countries. We estimate that development organisations substantially increased the amount of development assistance for health provided in 2020. Continued efforts are needed to raise sufficient resources to mitigate the pandemic for the most vulnerable, and to help curtail the pandemic for all. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.
|
|
| 4. |
|
|
| 5. |
- Bravo, L, et al.
(författare)
-
- 2021
-
swepub:Mat__t
|
|
| 6. |
|
|
| 7. |
- Tabiri, S, et al.
(författare)
-
- 2021
-
swepub:Mat__t
|
|
| 8. |
- Feigin, Valery L., et al.
(författare)
-
Global, regional, and national burden of stroke and its risk factors, 1990-2019 : a systematic analysis for the Global Burden of Disease Study 2019
- 2021
-
Ingår i: Lancet Neurology. - : Elsevier. - 1474-4422 .- 1474-4465. ; 20:10, s. 795-820
-
Tidskriftsartikel (refereegranskat)abstract
- Background Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels. Methods We applied GBD 2019 analytical tools to calculate stroke incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and the population attributable fraction (PAF) of DALYs (with corresponding 95% uncertainty intervals [UIs]) associated with 19 risk factors, for 204 countries and territories from 1990 to 2019. These estimates were provided for ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and all strokes combined, and stratified by sex, age group, and World Bank country income level. Findings In 2019, there were 12.2 million (95% UI 11.0-13.6) incident cases of stroke, 101 million (93.2-111) prevalent cases of stroke, 143 million (133-153) DALYs due to stroke, and 6.55 million (6.00-7.02) deaths from stroke. Globally, stroke remained the second-leading cause of death (11.6% [10.8-12.2] of total deaths) and the third-leading cause of death and disability combined (5.7% [5.1-6.2] of total DALYs) in 2019. From 1990 to 2019, the absolute number of incident strokes increased by 70.0% (67.0-73.0), prevalent strokes increased by 85.0% (83.0-88.0), deaths from stroke increased by 43.0% (31.0-55.0), and DALYs due to stroke increased by 32.0% (22.0-42.0). During the same period, age-standardised rates of stroke incidence decreased by 17.0% (15.0-18.0), mortality decreased by 36.0% (31.0-42.0), prevalence decreased by 6.0% (5.0-7.0), and DALYs decreased by 36.0% (31.0-42.0). However, among people younger than 70 years, prevalence rates increased by 22.0% (21.0-24.0) and incidence rates increased by 15.0% (12.0-18.0). In 2019, the age-standardised stroke-related mortality rate was 3.6 (3.5-3.8) times higher in the World Bank low-income group than in the World Bank high-income group, and the age-standardised stroke-related DALY rate was 3.7 (3.5-3.9) times higher in the low-income group than the high-income group. Ischaemic stroke constituted 62.4% of all incident strokes in 2019 (7.63 million [6.57-8.96]), while intracerebral haemorrhage constituted 27.9% (3.41 million [2.97-3.91]) and subarachnoid haemorrhage constituted 9.7% (1.18 million [1.01-1.39]). In 2019, the five leading risk factors for stroke were high systolic blood pressure (contributing to 79.6 million [67.7-90.8] DALYs or 55.5% [48.2-62.0] of total stroke DALYs), high body-mass index (34.9 million [22.3-48.6] DALYs or 24.3% [15.7-33.2]), high fasting plasma glucose (28.9 million [19.8-41.5] DALYs or 20.2% [13.8-29.1]), ambient particulate matter pollution (28.7 million [23.4-33.4] DALYs or 20.1% [16.6-23.0]), and smoking (25.3 million [22.6-28.2] DALYs or 17.6% [16.4-19.0]). Interpretation The annual number of strokes and deaths due to stroke increased substantially from 1990 to 2019, despite substantial reductions in age-standardised rates, particularly among people older than 70 years. The highest age-standardised stroke-related mortality and DALY rates were in the World Bank low-income group. The fastest-growing risk factor for stroke between 1990 and 2019 was high body-mass index. Without urgent implementation of effective primary prevention strategies, the stroke burden will probably continue to grow across the world, particularly in low-income countries.
|
|
| 9. |
|
|
| 10. |
|
|
| 11. |
- Charara, Raghid, et al.
(författare)
-
The Burden of Mental Disorders in the Eastern Mediterranean Region, 1990-2013
- 2017
-
Ingår i: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 12:1
-
Tidskriftsartikel (refereegranskat)abstract
- The Eastern Mediterranean Region (EMR) is witnessing an increase in chronic disorders, including mental illness. With ongoing unrest, this is expected to rise. This is the first study to quantify the burden of mental disorders in the EMR. We used data from the Global Burden of Disease study (GBD) 2013. DALYs (disability-adjusted life years) allow assessment of both premature mortality (years of life lost-YLLs) and nonfatal outcomes (years lived with disability-YLDs). DALYs are computed by adding YLLs and YLDs for each age-sex-country group. In 2013, mental disorders contributed to 5.6% of the total disease burden in the EMR (1894 DALYS/100,000 population): 2519 DALYS/100,000 (2590/100,000 males, 2426/100,000 females) in high-income countries, 1884 DALYS/100,000 (1618/100,000 males, 2157/100,000 females) in middle-income countries, 1607 DALYS/100,000 (1500/100,000 males, 1717/100,000 females) in low-income countries. Females had a greater proportion of burden due to mental disorders than did males of equivalent ages, except for those under 15 years of age. The highest proportion of DALYs occurred in the 25-49 age group, with a peak in the 35-39 years age group (5344 DALYs/100,000). The burden of mental disorders in EMR increased from 1726 DALYs/100,000 in 1990 to 1912 DALYs/100,000 in 2013 (10.8% increase). Within the mental disorders group in EMR, depressive disorders accounted for most DALYs, followed by anxiety disorders. Among EMR countries, Palestine had the largest burden of mental disorders. Nearly all EMR countries had a higher mental disorder burden compared to the global level. Our findings call for EMR ministries of health to increase provision of mental health services and to address the stigma of mental illness. Moreover, our results showing the accelerating burden of mental health are alarming as the region is seeing an increased level of instability. Indeed, mental health problems, if not properly addressed, will lead to an increased burden of diseases in the region.
|
|
| 12. |
|
|
| 13. |
- Tran, K. B., et al.
(författare)
-
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019
- 2022
-
Ingår i: Lancet. - 0140-6736. ; 400:10352, s. 563-591
-
Tidskriftsartikel (refereegranskat)abstract
- Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
|
|
| 14. |
|
|
| 15. |
|
|
| 16. |
- Ikuta, K. S., et al.
(författare)
-
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
- 2022
-
Ingår i: Lancet. - : Elsevier BV. - 0140-6736. ; 400:10369, s. 2221-2248
-
Tidskriftsartikel (refereegranskat)abstract
- Background Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with drug-resistant infections and sepsis and found that infections remain a leading cause of death globally. Understanding the global burden of common bacterial pathogens (both susceptible and resistant to antimicrobials) is essential to identify the greatest threats to public health. To our knowledge, this is the first study to present global comprehensive estimates of deaths associated with 33 bacterial pathogens across 11 major infectious syndromes. Methods We estimated deaths associated with 33 bacterial genera or species across 11 infectious syndromes in 2019 using methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, in addition to a subset of the input data described in the Global Burden of Antimicrobial Resistance 2019 study. This study included 343 million individual records or isolates covering 11 361 study-location-years. We used three modelling steps to estimate the number of deaths associated with each pathogen: deaths in which infection had a role, the fraction of deaths due to infection that are attributable to a given infectious syndrome, and the fraction of deaths due to an infectious syndrome that are attributable to a given pathogen. Estimates were produced for all ages and for males and females across 204 countries and territories in 2019. 95% uncertainty intervals (UIs) were calculated for final estimates of deaths and infections associated with the 33 bacterial pathogens following standard GBD methods by taking the 2.5th and 97.5th percentiles across 1000 posterior draws for each quantity of interest. Findings From an estimated 13.7 million (95% UI 10.9-17.1) infection-related deaths in 2019, there were 7.7 million deaths (5.7-10.2) associated with the 33 bacterial pathogens (both resistant and susceptible to antimicrobials) across the 11 infectious syndromes estimated in this study. We estimated deaths associated with the 33 bacterial pathogens to comprise 13.6% (10.2-18.1) of all global deaths and 56.2% (52.1-60.1) of all sepsis-related deaths in 2019. Five leading pathogens-Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Klebsiella pneumoniae, and Pseudomonas aeruginosa-were responsible for 54.9% (52.9-56.9) of deaths among the investigated bacteria. The deadliest infectious syndromes and pathogens varied by location and age. The age-standardised mortality rate associated with these bacterial pathogens was highest in the sub-Saharan Africa super-region, with 230 deaths (185-285) per 100 000 population, and lowest in the high-income super-region, with 52.2 deaths (37.4-71.5) per 100 000 population. S aureus was the leading bacterial cause of death in 135 countries and was also associated with the most deaths in individuals older than 15 years, globally. Among children younger than 5 years, S pneumoniae was the pathogen associated with the most deaths. In 2019, more than 6 million deaths occurred as a result of three bacterial infectious syndromes, with lower respiratory infections and bloodstream infections each causing more than 2 million deaths and peritoneal and intra-abdominal infections causing more than 1 million deaths. Interpretation The 33 bacterial pathogens that we investigated in this study are a substantial source of health loss globally, with considerable variation in their distribution across infectious syndromes and locations. Compared with GBD Level 3 underlying causes of death, deaths associated with these bacteria would rank as the second leading cause of death globally in 2019; hence, they should be considered an urgent priority for intervention within the global health community. Strategies to address the burden of bacterial infections include infection prevention, optimised use of antibiotics, improved capacity for microbiological analysis, vaccine development, and improved and more pervasive use of available vaccines. These estimates can be used to help set priorities for vaccine need, demand, and development. Copyright (c) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
|
|
| 17. |
- Glasbey, JC, et al.
(författare)
-
- 2021
-
swepub:Mat__t
|
|
| 18. |
- Moradi-Lakeh, Maziar, et al.
(författare)
-
Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013 : findings from the Global Burden of Disease Study 2013
- 2017
-
Ingår i: Annals of the Rheumatic Diseases. - : BMJ. - 1468-2060 .- 0003-4967. ; 76, s. 1365-1373
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVES: We used findings from the Global Burden of Disease Study 2013 to report the burden of musculoskeletal disorders in the Eastern Mediterranean Region (EMR).METHODS: The burden of musculoskeletal disorders was calculated for the EMR's 22 countries between 1990 and 2013. A systematic analysis was performed on mortality and morbidity data to estimate prevalence, death, years of live lost, years lived with disability and disability-adjusted life years (DALYs).RESULTS: For musculoskeletal disorders, the crude DALYs rate per 100 000 increased from 1297.1 (95% uncertainty interval (UI) 924.3-1703.4) in 1990 to 1606.0 (95% UI 1141.2-2130.4) in 2013. During 1990-2013, the total DALYs of musculoskeletal disorders increased by 105.2% in the EMR compared with a 58.0% increase in the rest of the world. The burden of musculoskeletal disorders as a proportion of total DALYs increased from 2.4% (95% UI 1.7-3.0) in 1990 to 4.7% (95% UI 3.6-5.8) in 2013. The range of point prevalence (per 1000) among the EMR countries was 28.2-136.0 for low back pain, 27.3-49.7 for neck pain, 9.7-37.3 for osteoarthritis (OA), 0.6-2.2 for rheumatoid arthritis and 0.1-0.8 for gout. Low back pain and neck pain had the highest burden in EMR countries.CONCLUSIONS: This study shows a high burden of musculoskeletal disorders, with a faster increase in EMR compared with the rest of the world. The reasons for this faster increase need to be explored. Our findings call for incorporating prevention and control programmes that should include improving health data, addressing risk factors, providing evidence-based care and community programmes to increase awareness.
|
|
| 19. |
|
|
| 20. |
- Sheena, B. S., et al.
(författare)
-
Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
- 2022
-
Ingår i: Lancet Gastroenterology & Hepatology. - : Elsevier BV. - 2468-1253. ; 7:9, s. 796-829
-
Tidskriftsartikel (refereegranskat)abstract
- Background Combating viral hepatitis is part of the UN Sustainable Development Goals (SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector Strategy on Viral Hepatitis (WHO-GHSS) and Interim Guidance for Country Validation of Viral Hepatitis Elimination (WHO Interim Guidance). We estimated the global, regional, and national prevalence of hepatitis B virus (HBV), as well as mortality and disability-adjusted life-years (DALYs) due to HBV, as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. This included estimates for 194 WHO member states, for which we compared our estimates to WHO elimination targets. Methods The primary data sources were population-based serosurveys, claims and hospital discharges, cancer registries, vital registration systems, and published case series. We estimated chronic HBV infection and the burden of HBV-related diseases, defined as an aggregate of cirrhosis due to hepatitis B, liver cancer due to hepatitis B, and acute hepatitis B. We used DisMod-MR 2.1, a Bayesian mixed-effects meta-regression tool, to estimate the prevalence of chronic HBV infection, cirrhosis, and aetiological proportions of cirrhosis. We used mortality-to-incidence ratios modelled with spatiotemporal Gaussian process regression to estimate the incidence of liver cancer. We used the Cause of Death Ensemble modelling (CODEm) model, a tool that selects models and covariates on the basis of out-ofsample performance, to estimate mortality due to cirrhosis, liver cancer, and acute hepatitis B. Findings In 2019, the estimated global, all-age prevalence of chronic HBV infection was 4 center dot 1% (95% uncertainty interval [UI] 3 center dot 7 to 4 center dot 5), corresponding to 316 million (284 to 351) infected people. There was a 31 center dot 3% (29 center dot 0 to 33 center dot 9) decline in all-age prevalence between 1990 and 2019, with a more marked decline of 76 center dot 8% (76 center dot 2 to 77 center dot 5) in prevalence in children younger than 5 years. HBV-related diseases resulted in 555 000 global deaths (487 000 to 630 000) in 2019. The number of HBV-related deaths increased between 1990 and 2019 (by 5 center dot 9% [-5 center dot 6 to 19 center dot 2]) and between 2015 and 2019 (by 2 center dot 9% [-5 center dot 9 to 11 center dot 3]). By contrast, all-age and age-standardised death rates due to HBV-related diseases decreased during these periods. We compared estimates for 2019 in 194 WHO locations to WHO-GHSS 2020 targets, and found that four countries achieved a 10% reduction in deaths, 15 countries achieved a 30% reduction in new cases, and 147 countries achieved a 1% prevalence in children younger than 5 years. As of 2019, 68 of 194 countries had already achieved the 2030 target proposed in WHO Interim Guidance of an all-age HBV-related death rate of four per 100 000. Interpretation The prevalence of chronic HBV infection declined over time, particularly in children younger than 5 years, since the introduction of hepatitis B vaccination. HBV-related death rates also decreased, but HBV-related death counts increased as a result of population growth, ageing, and cohort effects. By 2019, many countries had met the interim seroprevalence target for children younger than 5 years, but few countries had met the WHO-GHSS interim targets for deaths and new cases. Progress according to all indicators must be accelerated to meet 2030 targets, and there are marked disparities in burden and progress across the world. HBV interventions, such as vaccination, testing, and treatment, must be strategically supported and scaled up to achieve elimination.
|
|
| 21. |
- Adil, Nurmeen, et al.
(författare)
-
Evaluation of cytotoxicity of areca nut and its commercial products on normal human gingival fibroblast and oral squamous cell carcinoma cell lines
- 2021
-
Ingår i: Journal of Hazardous Materials. - : Elsevier. - 0304-3894 .- 1873-3336. ; 403
-
Tidskriftsartikel (refereegranskat)abstract
- Consumption of areca nut products is the most common cause of oral cancers, particularly in South Asian countries. This study evaluates the cytotoxic and necrotizing effects of areca nut and its formulations on normal human gingival fibroblasts (HGF-1) and oral squamous cell carcinoma (OSCC, CAL-27) cell lines. Identification of various carcinogens and adulterants using LC-HR-ESI-MS/MS analysis was performed in the extracts of areca nut and its products. Apart from alkaloids and flavonoids, a major adulterant, saccharin was found in all the samples of chalia (one of the most common chewing products of areca nut) in the ranges between 1.697-7.170 mg/g of the sample. Cytotoxic studies showed that most of the areca nut products were found cytotoxic to HGF-1 cells while being relatively non-cytotoxic against CAL-27 cells, rather they promote the growth of cancer cells. Our findings revealed that the components of areca nut and its products were injurious to HGF-1 cells and caused necrosis, which may attenuate HGF-1 protection toward oral epithelial cells. Moreover, the non-cytotoxic effect of these products on cancer cell lines suggests further predisposal of the habitual chewers for developing oral carcinomas. This study will give a better understanding of the hazardous effects of areca nut products.
|
|
| 22. |
- Alvarez, E. M., et al.
(författare)
-
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
- 2022
-
Ingår i: Lancet Oncology. - : Elsevier BV. - 1470-2045. ; 23:1, s. 27-52
-
Tidskriftsartikel (refereegranskat)abstract
- Background In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15-39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15-39 years to define adolescents and young adults. Findings There were 1.19 million (95% UI 1.11-1.28) incident cancer cases and 396 000 (370 000-425 000) deaths due to cancer among people aged 15-39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59.6 [54.5-65.7] per 100 000 person-years) and high-middle SDI countries (53.2 [48.8-57.9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14.2 [12.9-15.6] per 100 000 person-years) and middle SDI (13.6 [12.6-14.8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23.5 million (21.9-25.2) DALYs to the global burden of disease, of which 2.7% (1.9-3.6) came from YLDs and 97.3% (96.4-98.1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.
|
|
| 23. |
|
|
| 24. |
- Aziz, Sarkar, et al.
(författare)
-
Estimation of the prevalence of Hemoglobinopathies in Erbil governorate, Kurdistan region of Iraq
- 2022
-
Ingår i: IRAQI JOURNAL OF HEMATOLOGY. - : Medknow. - 2072-8069 .- 2543-2702. ; 11:1, s. 19-24
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Thalassemia syndromes and structural hemoglobin variants generate blood crisis of variable clinical symptoms, ranging from mild-to-moderate hematological disorder to severe, lifelong, transfusion-dependent anemia. The aim of current study was to uncover the prevalence of thalassemia and other hemoglobinopathies in the Erbil governorate, Kurdistan region of Iraq. MATERIALS AND METHODS: The available data of thalassemia major, thalassemia intermedia, sickle cell disease, sickle cell trait, and HbH and HbE until the end of 2020 were collected retrospectively from Erbil Thalassemia Center in Erbil governorate, Kurdistan region of Iraq and analyzed by using Microsoft Excel (Version 2016). RESULTS: An increase in the prevalence of thalassemia syndromes from 30.8/100,000 in 2015 to 37.3/100,000 individuals in the population in 2020 was revealed. The prevalence of all hemoglobinopathies combined increased from 31.9/100,000 to 42.7/100,000 individuals of the population. Thalassemia major was the predominant condition among the hemoglobinopathies with 758 (78.71%) cases out of 963 cases at the end of 2020. CONCLUSION: This rise might be attributed to a large number of consanguineous marriages, the lack of effective prevention programs, and poor legislation. There is an emergent requirement for a preventive program, entailing identification of carriers, genetic counseling, guidelines to differentiate between other microcytic anemias with thalassemia traits, antenatal diagnosis, public education, and sustained legislation.
|
|
| 25. |
|
|
| 26. |
|
|
| 27. |
- Sid Ahmed, Mazen, 1970-, et al.
(författare)
-
Association of blaVIM-2, blaPDC-35, blaOXA-10, blaOXA-488 and blaVEB-9 β-Lactamase Genes with Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa
- 2022
-
Ingår i: Antibiotics. - : MDPI. - 2079-6382. ; 11:2
-
Tidskriftsartikel (refereegranskat)abstract
- Ceftazidime-avibactam and ceftolozane-tazobactam are approved for the treatment of complicated Gram-negative bacterial infections including multidrug-resistant (MDR) Pseudomonas aeruginosa. Resistance to both agents has been reported, but the underlying mechanisms have not been fully explored. This study aimed to correlate β-lactamases with phenotypic resistance to ceftazidime-avibactam and/or ceftolozane-tazobactam in MDR-P. aeruginosa from Qatar. A total of 525 MDR-P. aeruginosa isolates were collected from clinical specimens between 2014 and 2017. Identification and antimicrobial susceptibility were performed by the BD PhoenixTM system and gradient MIC test strips. Of the 75 sequenced MDR isolates, 35 (47%) were considered as having difficult-to-treat resistance, and 42 were resistant to ceftazidime-avibactam (37, 49.3%), and/or ceftolozane-tazobactam (40, 53.3%). They belonged to 12 sequence types, with ST235 being predominant (38%). Most isolates (97.6%) carried one or more β-lactamase genes, with blaOXA-488 (19%) and blaVEB-9 (45.2%) being predominant. A strong association was detected between class B β-lactamase genes and both ceftazidime-avibactam and ceftolozane-tazobactam resistance, while class A genes were associated with ceftolozane-tazobactam resistance. Co-resistance to ceftazidime-avibactam and ceftolozane-tazobactam correlated with the presence of blaVEB-9, blaPDC-35, blaVIM-2, blaOXA-10 and blaOXA-488. MDR-P. aeruginosa isolates resistant to both combination drugs were associated with class B β-lactamases (blaVIM-2) and class D β-lactamases (blaOXA-10), while ceftolozane-tazobactam resistance was associated with class A (blaVEB-9), class C (blaVPDC-35), and class D β-lactamases (blaOXA-488).
|
|
| 28. |
|
|
| 29. |
|
|
| 30. |
- Sid Ahmed, Mazen, 1970-, et al.
(författare)
-
Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa isolated from bloodstream infections from Qatar
- 2021
-
Ingår i: Annals of Medicine. - : Taylor & Francis. - 0785-3890 .- 1365-2060. ; 53:1, s. 2345-2353
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Bloodstream infections (BSIs) caused by multidrug-resistant (MDR)-Pseudomonas aeruginosa are associated with poor clinical outcomes, at least partly due to delayed appropriate antimicrobial therapy. The characteristics of MDR-P. aeruginosa bloodstream isolates have not been evaluated in Qatar. Our study aimed to examine in vitro susceptibility, clinical and molecular characteristics, and mechanisms of resistance of MDR-P. aeruginosa bloodstream isolates from Qatar.Materials and methods: We included all MDR-P. aeruginosa isolated from blood cultures taken between October 2014 and September 2017. Blood cultures were processed using BD BACTEC™ FX automated system. BD Phoenix™ was used for identification, Liofilchem® MIC Test Strips for MIC determination. Whole-genome sequencing was performed using the Illumina-HiSeq-2000.Results: Out of 362 P. aeruginosa bloodstream isolates, 16 (4.4%) were MDR. The median patient age was 55 years (range 43-81) and all patients presented with septic shock. Most patients received meropenem (12/16) and/or colistin (10/16). Clinical response was achieved in eight patients, and five patients died within 30-days. MDR-P. aeruginosa isolates belonged to 13 different sequence types. All isolates were non-susceptible to cefepime and ciprofloxacin. The most active agents were colistin (16/16) and aztreonam (10/16). Seven isolates produced blaVIM, and four possessed genes encoding extended-spectrum β-lactamases. Aminoglycoside modifying enzymes were present in 15/16, transferable qnr-mediated quinolone resistance gene was detected in 3/16, and the novel ciprofloxacin modifying enzyme CrpP-encoding gene in one isolate.Conclusion: MDR-P. aeruginosa BSIs are relatively uncommon in Qatar but are highly resistant, harbour multiple resistance genes, and are commonly associated with unfavourable clinical outcomes. Colistin was the only agent with consistent activity against the study isolates.Key messagesMDR-P. aeruginosa constituted <5% of P. aeruginosa blood isolates over three years.Typical risk factors for MDR infections were highly prevalent in the study population and overall clinical outcomes are consistent with those previously reported.Colistin was the only agent with consistent antibacterial activity against the study isolates.
|
|
| 31. |
- Sid Ahmed, Mazen, 1970-, et al.
(författare)
-
Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar
- 2019
-
Ingår i: Journal of Antimicrobial Chemotherapy. - : Oxford University Press. - 0305-7453 .- 1460-2091. ; 74:12, s. 3497-3504
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVES: To investigate the in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against clinical isolates of MDR Pseudomonas aeruginosa from Qatar, as well as the mechanisms of resistance.METHODS: MDR P. aeruginosa isolated between October 2014 and September 2015 from all public hospitals in Qatar were included. The BD PhoenixTM system was used for identification and initial antimicrobial susceptibility testing, while Liofilchem MIC Test Strips (Liofilchem, Roseto degli Abruzzi, Italy) were used for confirmation of ceftazidime/avibactam and ceftolozane/tazobactam susceptibility. Ten ceftazidime/avibactam- and/or ceftolozane/tazobactam-resistant isolates were randomly selected for WGS.RESULTS: A total of 205 MDR P. aeruginosa isolates were included. Of these, 141 (68.8%) were susceptible to ceftazidime/avibactam, 129 (62.9%) were susceptible to ceftolozane/tazobactam, 121 (59.0%) were susceptible to both and 56 (27.3%) were susceptible to neither. Twenty (9.8%) isolates were susceptible to ceftazidime/avibactam but not to ceftolozane/tazobactam and only 8 (3.9%) were susceptible to ceftolozane/tazobactam but not to ceftazidime/avibactam. Less than 50% of XDR isolates were susceptible to ceftazidime/avibactam or ceftolozane/tazobactam. The 10 sequenced isolates belonged to six different STs and all produced AmpC and OXA enzymes; 5 (50%) produced ESBL and 4 (40%) produced VIM enzymes.CONCLUSIONS: MDR P. aeruginosa susceptibility rates to ceftazidime/avibactam and ceftolozane/tazobactam were higher than those to all existing antipseudomonal agents, except colistin, but were less than 50% in extremely resistant isolates. Non-susceptibility to ceftazidime/avibactam and ceftolozane/tazobactam was largely due to the production of ESBL and VIM enzymes. Ceftazidime/avibactam and ceftolozane/tazobactam are possible options for some patients with MDR P. aeruginosa in Qatar.
|
|
| 32. |
- Abdullah, Gamil M. S., et al.
(författare)
-
Effect of titanium dioxide as nanomaterials on mechanical and durability properties of rubberised concrete by applying RSM modelling and optimizations
- 2024
-
Ingår i: Frontiers in Materials. - : Frontiers Media SA. - 2296-8016. ; 11
-
Tidskriftsartikel (refereegranskat)abstract
- The use of rubber aggregates derived from discarded rubber tyres in concrete is a pioneering approach to replacing natural aggregate (NA) and promoting sustainable building practices. Recycled aggregate in concrete serves the dual purpose of alleviating the accumulation of discarded rubber tyres on the planet and providing a more sustainable alternative to decreasing natural aggregate. Due to fact that the crumb rubber (CR) decreases the strength when used in concrete, incorporating titanium dioxide (TiO2) as a nanomaterial to counteract the decrease in strength of crumb rubber concrete is a potential solution. Response Surface Methodology was developed to generate sixteen RUNs which contains different mix design by providing two input parameters like TiO2 at 1%, 1.5%, and 2% by cement weight and CR at 10%, 20%, and 30% as substitutions for volume of sand. These mixtures underwent testing for 28 days to evaluate their mechanical, deformation, and durability properties. Moreover, the compressive strength, tensile strength, flexural strength and elastic modulus were recorded by 51.40 MPa, 4.47 MPa, 5.91 MPa, and 40.15 GPa when 1.5% TiO2 and 10% CR were added in rubberised concrete after 28 days respectively. Furthermore, the incorporation of TiO2 led to reduced drying shrinkage and sorptivity in rubberized concrete, especially with increased TiO2 content. The study highlights that TiO2 inclusion refines pore size and densifies the interface between cement matrix and aggregate in hardened rubberized concrete. This transformative effect results in rubberized concrete demonstrating a commendable compressive strength comparable to normal concrete.
|
|
| 33. |
- Ali, A., et al.
(författare)
-
Metformin enhances LDL-cholesterol uptake by suppressing the expression of the pro-protein convertase subtilisin/kexin type 9 (PCSK9) in liver cells
- 2022
-
Ingår i: Endocrine. - : Springer Science and Business Media LLC. - 1355-008X .- 1559-0100. ; 76, s. 543-557
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose: Metformin (MF) intake associates with reduced levels of circulating low-density lipoprotein-cholesterol (LDL-C). This has been attributed to the activation of AMPK, which differentially regulates the expression of multiple genes involved in cholesterol synthesis and trafficking. However, the exact mechanism underlying the LDL-C lowering effect of MF remains ambiguous. Methods: MF-treated Hep-G2 and HuH7 cells were evaluated for cell viability and the expression status of key lipid metabolism-related genes along with LDL-C uptake efficiency. Results: MF treatment resulted in decreased expression and secretion of PCSK9, increased expression of LDLR and enhanced LDL-C uptake in hepatocytes. It also resulted in increased expression of activated AMPK (p-AMPK) and decreased expression of SREBP2 and HNF-1α proteins. Transcriptomic analysis of MF-treated Hep-G2 cells confirmed these findings and showed that other key lipid metabolism-related genes including those that encode apolipoproteins (APOB, APOC2, APOC3 and APOE), MTTP and LIPC are downregulated. Lastly, MF treatment associated with reduced HMG-CoA reductase expression and activity. Conclusions: These findings suggest that MF treatment reduces circulating LDL-C levels by suppressing PCSK9 expression and enhancing LDLR expression; hence the potential therapeutic utility of MF in hypercholesterolemia.
|
|
| 34. |
- Ali Hamad, Rebeen, 1989-, et al.
(författare)
-
Efficacy of Imbalanced Data Handling Methods on Deep Learning for Smart Homes Environments
- 2020
-
Ingår i: SN Computer Science. - Heidelberg : Springer Berlin/Heidelberg. - 2661-8907 .- 2662-995X. ; 1:4
-
Tidskriftsartikel (refereegranskat)abstract
- Human activity recognition as an engineering tool as well as an active research field has become fundamental to many applications in various fields such as health care, smart home monitoring and surveillance. However, delivering sufficiently robust activity recognition systems from sensor data recorded in a smart home setting is a challenging task. Moreover, human activity datasets are typically highly imbalanced because generally certain activities occur more frequently than others. Consequently, it is challenging to train classifiers from imbalanced human activity datasets. Deep learning algorithms perform well on balanced datasets, yet their performance cannot be promised on imbalanced datasets. Therefore, we aim to address the problem of class imbalance in deep learning for smart home data. We assess it with Activities of Daily Living recognition using binary sensors dataset. This paper proposes a data level perspective combined with a temporal window technique to handle imbalanced human activities from smart homes in order to make the learning algorithms more sensitive to the minority class. The experimental results indicate that handling imbalanced human activities from the data-level outperforms algorithms level and improved the classification performance. © The Author(s) 2020
|
|
| 35. |
- Ali Hamad, Rebeen, 1989-, et al.
(författare)
-
Efficient Activity Recognition in Smart Homes Using Delayed Fuzzy Temporal Windows on Binary Sensors
- 2020
-
Ingår i: IEEE journal of biomedical and health informatics. - Piscataway : Institute of Electrical and Electronics Engineers (IEEE). - 2168-2194 .- 2168-2208. ; 24:2, s. 387-395
-
Tidskriftsartikel (refereegranskat)abstract
- Human activity recognition has become an active research field over the past few years due to its wide application in various fields such as health-care, smart home monitoring, and surveillance. Existing approaches for activity recognition in smart homes have achieved promising results. Most of these approaches evaluate real-time recognition of activities using only sensor activations that precede the evaluation time (where the decision is made). However, in several critical situations, such as diagnosing people with dementia, “preceding sensor activations” are not always sufficient to accurately recognize the inhabitant's daily activities in each evaluated time. To improve performance, we propose a method that delays the recognition process in order to include some sensor activations that occur after the point in time where the decision needs to be made. For this, the proposed method uses multiple incremental fuzzy temporal windows to extract features from both preceding and some oncoming sensor activations. The proposed method is evaluated with two temporal deep learning models (convolutional neural network and long short-term memory), on a binary sensor dataset of real daily living activities. The experimental evaluation shows that the proposed method achieves significantly better results than the real-time approach, and that the representation with fuzzy temporal windows enhances performance within deep learning models. © Copyright 2020 IEEE
|
|
| 36. |
- Ali Hamad, Rebeen, 1989-, et al.
(författare)
-
Stability analysis of the t-SNE algorithm for human activity pattern data
- 2018
-
Konferensbidrag (refereegranskat)abstract
- Health technological systems learning from and reacting on how humans behave in sensor equipped environments are today being commercialized. These systems rely on the assumptions that training data and testing data share the same feature space, and residing from the same underlying distribution - which is commonly unrealistic in real-world applications. Instead, the use of transfer learning could be considered. In order to transfer knowledge between a source and a target domain these should be mapped to a common latent feature space. In this work, the dimensionality reduction algorithm t-SNE is used to map data to a similar feature space and is further investigated through a proposed novel analysis of output stability. The proposed analysis, Normalized Linear Procrustes Analysis (NLPA) extends the existing Procrustes and Local Procrustes algorithms for aligning manifolds. The methods are tested on data reflecting human behaviour patterns from data collected in a smart home environment. Results show high partial output stability for the t-SNE algorithm for the tested input data for which NLPA is able to detect clusters which are individually aligned and compared. The results highlight the importance of understanding output stability before incorporating dimensionality reduction algorithms into further computation, e.g. for transfer learning.
|
|
| 37. |
- Ali Hamad, Rebeen, 1989-
(författare)
-
Towards Reliable, Stable and Fast Learning for Smart Home Activity Recognition
- 2022
-
Licentiatavhandling (övrigt vetenskapligt/konstnärligt)abstract
- The current population age grows increasingly in industrialized societies and calls for more intelligent tools to monitor human activities. The aims of these intelligent tools are often to support senior people in their homes, to keep track of their daily activities, and to early detect potential health problems to facilitate a long and independent life. The recent advancements of smart environments using miniaturized sensors and wireless communications have facilitated unobtrusively human activity recognition. Human activity recognition has been an active field of research due to its broad applications in different areas such as healthcare and smart home monitoring. This thesis project develops work on machine learning systems to improve the understanding of human activity patterns in smart home environments. One of the contributions of this research is to process and share information across multiple smart homes to reduce the learning time, reduce the need and effort to recollect the training data, as well as increase the accuracy for applications such as activity recognition. To achieve that, several contributions are presented to pave the way to transfer knowledge among smart homes that includes the following studies. Firstly, a method to align manifolds is proposed to facilitate transfer learning. Secondly, we propose a method to further improve the performance of activity recognition over the existing methods. Moreover, we explore imbalanced class problems in human activity recognition and propose a method to handle imbalanced human activities. The summary of these studies are provided below. In our work, it is hypothesized that aligning learned low-dimensional manifolds from disparate datasets could be used to transfer knowledge between different but related datasets. The t-distributed Stochastic Neighbor Embedding(t-SNE) is used to project the high-dimensional input dataset into low-dimensional manifolds. However, since t-SNE is a stochastic algorithm and there is a large variance of t-SNE maps, a thorough analysis of the stability is required before applying Transfer learning. In response to this, an extension to Local Procrustes Analysis called Normalized Local Procrustes Analysis (NLPA) is proposed to non-linearly align manifolds by using locally linear mappings to test the stability of t-SNE low-dimensional manifolds. Experiments show that the disparity from using NLPA to align low-dimensional manifolds decreases by order of magnitude compared to the disparity obtained by Procrustes Analysis (PA). NLPA outperforms PA and provides much better alignments for the low-dimensional manifolds. This indicates that t-SNE low-dimensional manifolds are locally stable, which is the part of the contribution in this thesis.Human activity recognition in smart homes shows satisfying recognition results using existing methods. Often these methods process sensor readings that precede the evaluation time (where the decision is made) to evaluate and deliver real-time human activity recognition. However, there are several critical situations, such as diagnosing people with dementia where "preceding sensor activations" are not always sufficient to accurately recognize the resident's daily activities in each evaluated time. To improve performance, we propose a method that delays the recognition process to include some sensor activations that occur after the point in time where the decision needs to be made. For this, the proposed method uses multiple incremental fuzzy temporal windows to extract features from both preceding and some oncoming sensor activations. The proposed method is evaluated with two temporal deep learning models: one-dimensional convolutional neural network (1D CNN) and long short-term memory (LSTM) on a binary sensor dataset of real daily living activities. The experimental evaluation shows that the proposed method achieves significantly better results than the previous state-of-the-art. Further, one of the main problems of activity recognition in a smart home setting is that the frequency and duration of human activities are intrinsically imbalanced. The huge difference in the number of observations for the categories means that many machine learning algorithms focus on the classification of the majority examples due to their increased prior probability while ignoring or misclassifying minority examples. This thesis explores well-known class imbalance approaches (synthetic minority over-sampling technique, cost-sensitive learning and ensemble learning) applied to activity recognition data with two temporal data pre-processing for the deep learning models LSTM and 1D CNN. This thesis proposes a data level perspective combined with a temporal window technique to handle imbalanced human activities from smart homes in order to make the learning algorithms more sensitive to the minority class. The experimental results indicate that handling imbalanced human activities from the data-level outperforms algorithm level and improved the classification performance.
|
|
| 38. |
- Bhutto, Shahzeb, et al.
(författare)
-
Effect of banana tree leaves ash as cementitious material on the durability of concrete against sulphate and acid attacks
- 2024
-
Ingår i: Heliyon. - : Elsevier. - 2405-8440. ; 10:7
-
Tidskriftsartikel (refereegranskat)abstract
- The construction industry's rapid growth poses challenges tied to raw material depletion and increased greenhouse gas emissions. To address this, alternative materials like agricultural residues are gaining prominence due to their potential to reduce carbon emissions and waste generation. In this context this research optimizes the use of banana leaves ash as a partial cement substitution, focusing on durability, and identifying the ideal cement-to-ash ratio for sustainable concrete. For this purpose, concrete mixes were prepared with BLA replacing cement partially in different proportions i.e. (0 %, 5 %, 10 %, 15 %, & 20 %) and were analyzed for their physical, mechanical and Durability (Acid and Sulphate resistance) properties. Compressive strength, acid resistance and sulphate resistance testing continued for 90 days with the intervals of 7, 28 and 90 days. The results revealed that up to 10 % incorporation of BLA improved compressive strength by 10 %, while higher BLA proportions (up to 20 %) displayed superior performance in durability tests as compared to the conventional mix. The results reveal the potentials of banana leave ash to refine the concrete matrix by formation of addition C–S–H gel which leads towards a better performance specially in terms of durability aspect. Hence, banana leaf ash (BLA) is an efficient concrete ingredient, particularly up to 10 % of the mix. Beyond this threshold, it's still suitable for applications where extreme strength isn't the primary concern, because there may be a slight reduction in compressive strength.
|
|
| 39. |
|
|
| 40. |
|
|
| 41. |
|
|
| 42. |
|
|
| 43. |
- Kassimu, Kamaka, et al.
(författare)
-
Safety and Tolerability of an Antimalarial Herbal Remedy in Healthy Volunteers : An Open-Label, Single-Arm, Dose-Escalation Study on Maytenus senegalensis in Tanzania
- 2022
-
Ingår i: Tropical Medicine and Infectious Disease. - : MDPI. - 2414-6366. ; 7:12
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Though Maytenus senegalensis is one of the medicinal plants widely used in traditional medicine to treat infectious and inflammatory diseases in Africa, there is a lack of safety data regarding its use. Therefore, the study aimed to asselss the safety and tolerability of the antimalarial herbal remedy M. senegalensis. Material and Methods: The study design was an open-label, single-arm, dose-escalation. Twelve eligible male healthy Tanzanians aged 18 to 45 years were enrolled in four study dose groups. Volunteers' safety and tolerability post-investigational-product administration were monitored on days 0 to 7,14, and 56. Results: There were no deaths or serious adverse events in any of the study groups, nor any adverse events that resulted in premature discontinuation. The significant mean changes observed in WBC (p = 0.003), Neutrophils (p = 0.02), Lymphocytes (p = 0.001), Eosinophils (p = 0.009), Alanine aminotransferase (p = 0.002), Creatinine (p = 0.03) and Total bilirubin (p = 0.004) laboratory parameters were not associated with any signs of toxicity or clinical symptoms. Conclusions: M. senegalensis was demonstrated to be safe and tolerable when administered at a dose of 800 mg every eight hours a day for four days. This study design may be adapted to evaluate other herbal remedies.
|
|
| 44. |
- Kazmi, Bilal, et al.
(författare)
-
Towards a sustainable future : Bio-hydrogen production from food waste for clean energy generation
- 2024
-
Ingår i: Process Safety and Environmental Protection. - : Institution of Chemical Engineers. - 0957-5820 .- 1744-3598. ; 183, s. 555-567
-
Tidskriftsartikel (refereegranskat)abstract
- To address climate change, energy security, and waste management, new sustainable energy sources must be developed. This study uses Aspen Plus software to extract bio-H2 from food waste with the goal of efficiency and environmental sustainability. Anaerobic digestion, optimised to operate at 20–25 °C and keep ammonia at 3%, greatly boosted biogas production. The solvent [Emim][FAP], which is based on imidazolium, had excellent performance in purifying biogas. It achieved a high level of methane purity while consuming a minimal amount of energy, with a solvent flow rate of 13.415 m³ /h. Moreover, the utilization of higher temperatures (600–700 °C) during the bio-H2 generation phase significantly enhanced both the amount and quality of hydrogen produced. Parametric and sensitivity assessments were methodically performed at every stage. This integrated method was practicable and environmentally friendly, according to the economic assessment. H2 generation using steam reforming results in a TCC of 1.92 × 106 USD. The CO2 separation step has higher costs (TCC of 2.15 ×107 USD) due to ionic liquid washing and CO2 liquefaction. Compressor electricity consumption significantly impacts total operating cost (TOC), totaling 4.73 × 108 USD. showing its ability to reduce greenhouse gas emissions, optimize resource utilization, and promote energy sustainability. This study presents a sustainable energy solution that addresses climate and waste challenges.
|
|
| 45. |
- Khan, Abdul Ahad, et al.
(författare)
-
Algal biochar : A natural solution for the removal of Congo red dye from textile wastewater
- 2024
-
Ingår i: Journal of the Taiwan Institute of Chemical Engineers / Elsevier. - : Elsevier. - 1876-1070 .- 1876-1089.
-
Tidskriftsartikel (refereegranskat)abstract
- The present study was aimed at synthesizing algae-derived biochar to examine its effectiveness and adsorption capacity to remove Congo red dye. The independent variables such as dye concentration, adsorbent dose, and adsorption time were optimized by using a central composite design (CCD). An adsorption experiment was conducted to evaluate equilibrium using a detailed experimental design and characterized through XRD, TGA, SEM, EDX, and FTIR analysis. This paper also focuses on evaluating non-linear adsorption isotherm and kinetics to describe the adsorption mechanism along with applying an Artificial neural network to validate the removal efficiency. The maximum Congo red removal efficiency (96.14 %) and maximum adsorption capacity of algal biochar (186.94 mg/g) were achieved with the optimized parameters of 1 mg/L of dye concentration, 0.1 g of adsorbent dose, and 240 min of contact time. Adsorption behavior was well described by Langmuir isotherm and Pseudo-nth order. A multilayer perceptron (MLP) MLP 2–5–1 structure best validates the response. Overall, the study sheds light that Algal-derived biochar is a potential material for the elimination of Congo red dye and contributes to achieving sustainable development goals.
|
|
| 46. |
|
|
| 47. |
- Kocarnik, J. M., et al.
(författare)
-
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019
- 2022
-
Ingår i: Jama Oncology. - : American Medical Association (AMA). - 2374-2437 .- 2374-2445. ; 8:3, s. 420-488
-
Tidskriftsartikel (refereegranskat)abstract
- IMPORTANCE The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. OBJECTIVE To estimate cancer burden and trends globally for 204 countries and territories and by Sociodemographic Index (SDI) quintiles from 2010 to 2019. EVIDENCE REVIEW The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and over the past decade. Estimates are also provided by quintiles of the SDI, a composite measure of educational attainment, income per capita, and total fertility rate for those younger than 25 years. Estimates include 95% uncertainty intervals (UIs). FINDINGS In 2019, there were an estimated 23.6 million (95% UI, 22.2-24.9 million) new cancer cases (17.2 million when excluding nonmelanoma skin cancer) and 10.0 million (95% UI, 9.36-10.6 million) cancer deaths globally, with an estimated 250 million (235-264 million) DALYs due to cancer. Since 2010, these represented a 26.3%(95% UI, 20.3%-32.3%) increase in new cases, a 20.9%(95% UI, 14.2%-27.6%) increase in deaths, and a 16.0% (95% UI, 9.3%-22.8%) increase in DALYs. Among 22 groups of diseases and injuries in the GBD 2019 study, cancer was second only to cardiovascular diseases for the number of deaths, years of life lost, and DALYs globally in 2019. Cancer burden differed across SDI quintiles. The proportion of years lived with disability that contributed to DALYs increased with SDI, ranging from 1.4%(1.1%-1.8%) in the low SDI quintile to 5.7%(4.2%-7.1%) in the high SDI quintile. While the high SDI quintile had the highest number of new cases in 2019, the middle SDI quintile had the highest number of cancer deaths and YDALYs. From 2010 to 2019, the largest percentage increase in the numbers of cases and deaths occurred in the low and low-middle SDI quintiles. CONCLUSIONS AND RELEVANCE The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI. These results provide comprehensive and comparable estimates that can potentially inform efforts toward equitable cancer control around the world.
|
|
| 48. |
|
|
| 49. |
|
|
| 50. |
- Nur, Omer, et al.
(författare)
-
Effect of elevated concentrations of strontium and iron on the structural and dielectric characteristics of Ba(1-x-y)Sr(x)Ti Fe(y)O3 prepared through sol-gel technique
- 2012
-
Ingår i: Physica. B, Condensed matter. - : Elsevier. - 0921-4526 .- 1873-2135. ; 407:14, s. 2697-2704
-
Tidskriftsartikel (refereegranskat)abstract
- Nano-composite Ba1-xSr(x)TiO3 (BST), where x=0.01-0.50 and doped with different concentrations of iron Ba(1-x-y)Sr(x)TiFe(y)O3 (BSTF), where x=0.01 and y=0.01-0.05 powders were prepared by sol-gel method. The effect of increasing the iron and strontium concentrations substituted in Barium strontium titanate system will be studied. The prepared samples have a tetragonal crystalline phase after sintering for 1 h at 750 degrees C in air. The structural and the morphological features of the systems have been studied using X-ray diffraction (XRD), transmission electron microscope (TEM) and scanning electron microscope (SEM). The dielectric properties of the BST and BSTF systems have been investigated as a function of temperature and frequency. The dielectric measurements are carried out in the frequency range 42 Hz-1 MHz, at a temperature ranging between 25 and 250 degrees C. The results showed a decrease in T-c temperature giving the following values 90 and 85 degrees C for B10ST and B10ST5F prepared powder samples, respectively, implying tetragonal, feroelectric phase at lower temperature into cubic, para-electric phase at temperature higher than T-c.
|
|
